CIK 0000879407
- Large accelerated filer
ARROWHEAD PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ARWR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460408024
- Phone
- +1 626-696-4702
- Business address
- 177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
- Former names
- ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
- 5 Insider Annual Insider Trading Report
- 4 Grant or award Chief Executive Officer acquired 978,000 shares (grant or award)
- 4 Grant or award Director acquired 50,000 shares (grant or award)
- 4 Grant or award Director acquired 50,000 shares (grant or award)
- 4 Grant or award Director acquired 80,000 shares (grant or award)
- 4 Grant or award Director acquired 80,000 shares (grant or award)
- 4 Grant or award VP, Strategy & Program Mgmt acquired 90,000 shares (grant or award)
- 4 Grant or award General Counsel acquired 145,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 145,000 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 380,000 shares (grant or award)
- 4 Shares withheld for taxes Chief Executive Officer gave up 300,444 shares (to pay taxes)
- 4 Open-market sale Director sold 12,000 shares at $6.72 ($80,640)
- 4/A Open-market sale Chief Financial Officer sold 20,000 shares at $8.00 ($160,000)
- 4 Open-market sale Chief Financial Officer sold 20,000 shares at $8.00 ($160,000)
- 4 Option exercise Chief Executive Officer acquired 15,772 shares (option exercise)
- 4 Grant or award Director acquired 8,517 shares (grant or award)
- 4 Shares withheld for taxes Chief Financial Officer gave up 6,263 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 13,675 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 13,048 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 17,969 shares (to pay taxes)
Page 15 of 25 · 497 filings